Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font

Globe NewsWire News Distribution Service

Last patient last visit in randomized, double-blind, SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease is scheduled for early June 2024 ROCHESTER, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of Semaphorin 4D (SEMA4D),…

Posted: 2024-05-15 22:00:00

Get Full News Story On GlobeNewsWire Press Release Service

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update - Newscast

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

Tue, 21 May 2024 04:14:00 GMT Following merger with Adaptive Phage Therapeutics in March, combined company reports funding sufficient to support important data readouts for ...

Globant Reports 2024 First Quarter Financial Results

Thu, 16 May 2024 06:15:00 GMT Note that reconciliations between Non-IFRS financial measures and IFRS operating results are disclosed at the end of this press release. First Quarter 2024 Financial Highlights Revenues rose to $ ...

Fortinet reports first quarter 2024 financial results

Wed, 15 May 2024 17:00:00 GMT We’re pleased to have executed with strong financial discipline in the first quarter leading to ... Send us your press releases to Disclaimer: The contents ...

Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update

Wed, 15 May 2024 15:01:00 GMT Financial Results for the Quarter Ended March 31 ... To the extent that statements contained in this press release are not descriptions of historical facts regarding Vaccinex, Inc.

Orezone Reports First Quarter 2024 Results

Mon, 13 May 2024 07:31:00 GMT Additional details are provided at the end of this press release. All dollar amounts are in USD unless otherwise stated and abbreviation “M” means million. 2024 FIRST QUARTER HIGHLIGHTS (All ...

Blow Us A Whistle